6 results about "Eugenia caryophyllata" patented technology

The application belongs to the field of plant genetic engineering, and particularly relates to a soybean eugenol synthesis gene GmEGS and application thereof. The application provides application of a soybean eugenol synthesis protein GmEGS or a nucleic acid molecule coding the soybean eugenol synthesis protein GmEGS in increasing the content of eugenol in soybean or improving the ability of soybean to resist Phytophthora sojae, the protein GmEGS includes a protein GmEGS1a, a protein GmEGS1c and a protein GmEGS2a, the amino acid sequences of the protein GmEGS1a, the protein GmEGS1c and the protein GmEGS2a are shown in SEQ ID NO. 1-3 in sequence, and the ORF of the nucleic acid includes nucleic acid molecules shown in SEQ ID NO. 4-6. The content of eugenol in soybean can be obviously increased by transforming a soybean plant with the biomaterial of the application, and meanwhile, the disease resistance of soybean to Phytophthora sojae can also be improved. The application provides a good theoretical basis for the molecular mechanism of disease resistance of soybean, and has important significance for molecular design breeding.

The present invention relates to a composition comprising delta-9-tetrahydrocannabinol (THC), alpha-bisabolol, guaiol, beta-caryophyllene and at least one terpene selected from the group consisting of linalool, alpha-humulene, nerolidol, caryophyllene oxide, alpha-pinene, camphene, beta-pinene, beta-myrcene, limonene, eucalyptol, ocimene, gamma-terpinene, terpinolene, alpha-terpinene, para-cymene, isopulegol and geraniol. The invention also relates to a pharmaceutical formulation comprising such composition. The pharmaceutical formulation according to the present invention may be used in medicine, specifically in the treatment and / or prevention of diseases associated with pain such as chronic cancer pain, somatic pain, visceral pain, central neuropathic pain, peripheral neuropathic pain or complex pain syndromes.

The invention belongs to the field of pesticides, and provides a bactericide composition for preventing and treating sorghum diseases and application of the bactericide composition, active ingredients comprise eugenol and chlorin iron, and the mass ratio of the eugenol to the chlorin iron is 1: 10-20: 1. The bactericide composition has an excellent synergistic effect on sorghum diseases; the composition can effectively reduce the usage amount of pesticides, alleviate the generation of drug resistance of diseases, alleviate environmental pollution, and is safe to crops through field observation.

The invention belongs to the field of plant genetic engineering, and particularly relates to a soybean eugenol synthesis gene GmEGS and application thereof. The invention provides application of a soybean eugenol synthetic protein GmEGS or a nucleic acid molecule encoding the soybean eugenol synthetic protein GmEGS in increasing the content of eugenol in soybeans or improving the resistance of the soybeans to phytophthora sojae. The protein GmEGS comprises a protein GmEGS1a, a protein GmEGS1c and a protein GmEGS2a, and the amino acid sequences of the protein GmEGS1a, the protein GmEGS1c and the protein GmEGS2a are sequentially shown as SEQ ID NO.1-3; the ORF of the nucleic acid comprises nucleic acid molecules as shown in SEQ ID NO. 4-6. When the biological material disclosed by the invention is used for transforming soybean plants, the content of eugenol in soybeans can be obviously increased, and meanwhile, the disease resistance of the soybeans to phytophthora sojae can also be improved. The invention provides a good theoretical basis for a soybean disease-resistant molecular mechanism, and has important significance for molecular design breeding.

The present invention describes a composition comprising beta-caryophyllene, docosahexaenoic acid and eugenol for use as analgesic and anti-inflammatory antioxidants for the central and peripheral nervous system, administered by oral route, the compounds are useful as analgesics for chronic pain disorders, chronic inflammatory pain, chronic neuralgia and as anti-inflammatory antioxidants for the central and peripheral nervous systems.

The present invention relates to the technical field of Mongolian medicine, and discloses a Mongolian medicine named Renqing Wugete Busan for treating Heretic lung disease. This Mongolian medicine is composed of twenty-six medicinal materials including Gentiana algida Pall., Aquilaria sinensis (Lour.) Gilg, Choerospatha eriostachya (Wall.) Miq., Santalum album Linn., Myristica fragrans Houtt., Gypsum Fibrosum, Adenophora stricta Miq., Aucklandia lappa Decne., Terminalia chebula Retz., Melia toosendan Sieb. et Zucc., Gardenia jasminoides Ellis, Sophora flavescens Ait., Potentilla discolor Bunge, Dianthus superbus Linn., Eugenia caryophyllata Thunb., Glycyrrhiza glabra Linn., Vitis vinifera L., Cyperus rotundus L., Cinnamomum cassia Presl, Punica granatum L., Carthamus tinctorius L., Ilex purpurea Hassk., Alpinia oxyphylla Miq., Piper longum L., Neptunea arthritica cumingii, Bistorta officinalis Z. in specific weight part ratios. In the formula, Vitis vinifera L. and Myristica fragrans Houtt. are monarch drugs, Ilex purpurea Hassk., Carthamus tinctorius L., Gypsum Fibrosum, Glycyrrhiza glabra Linn., Adenophora stricta Miq., Cyperus rotundus L., Choerospatha eriostachya (Wall.) Miq., Santalum album Linn., Aquilaria sinensis (Lour.) Gilg are ministerial drugs, and the rest are adjuvant and guiding drugs. The total weight part ratio of the monarch drugs to the ministerial drugs is 1:3.0 - 3.4, and the total weight part ratio of the heat-clearing medicinal materials to the stomach-warming medicinal materials among the adjuvant and guiding drugs is 1:1.1 - 1.5. The present invention realizes the synchronous regulation of the disorder of Heretic and Badagan through scientific ratio, and takes into account the treatment of lung symptoms and gastrointestinal functions.